Table 1.
Characteristics of the case definition development set (2006-2007) and validation set (2008-2009) n (%)
|
Development set (2006-2007) |
Validation set (2007-2008) |
|||||||
| Overall (n = 51) | EoE cases (n = 21) | Sensitive definition (n = 31) | Specific definition (n = 9) | Overall (n = 49) | EoE cases (n = 24) | Sensitive definition (n = 26) | Specific definition (n = 6) | |
| Age, yr (mean ± SD) | 42 ± 19 | 35 ± 16 | 40 ± 18 | 38 ± 19 | 48 ± 21 | 42 ± 15 | 49 ± 19 | 49 ± 19 |
| Male | 38 (75) | 16 (76) | 22 (71) | 7 (78) | 36 (73) | 20 (83) | 21 (81) | 4 (67) |
| Dysphagia | 24 (47) | 18 (86) | 28 (90) | 8 (89) | 19 (39) | 16 (67) | 18 (69) | 3 (50) |
| Esophageal foreign body | 15 (29) | 11 (52) | 14 (45) | 3 (33) | 8 (16) | 2 (8) | 4 (15) | 1 (17) |
| Rhinitis/sinusitis | 5 (10) | 2 (10) | 2 (6) | 1 (11) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Asthma | 3 (6) | 1 (5) | 1 (3) | 0 (0) | 2 (4) | 2 (8) | 2 (8) | 1 (17) |
| PPI use | 38 (75) | 17 (81) | 21 (68) | 9 (100) | 33 (67) | 12 (50) | 21 (81) | 6 (100) |
| Maximum eosinophil count, eos/hpf (mean ± SD) | 71 ± 53 | 103 ± 54 | 84 ± 58 | 93 ± 83 | 68 ± 71 | 77 ± 62 | 60 ± 35 | 43 ± 31 |
EoE: Eosinophilic esophagitis; PPI: Proton-pump inhibitor; eos/hpf: Eosinophils per high-power field.